(Q81544547)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Yukihiko Aikawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Kimiko Morimoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Tetsuya Yamamoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hisaaki Chaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Akira Hashiramoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hirokazu Narita

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Shuichi Hirono

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Shunichi Shiozawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

29 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

817-823

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nbt1412

9 January 2020

exact match

0 references

cites work

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition

1 reference

7 January 2021

Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

1 reference

7 January 2021

Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

1 reference

7 January 2021

Tumor necrosis factor inhibitors for rheumatoid arthritis

1 reference

7 January 2021

The benefit/risk profile of TNF-blocking agents: findings of a consensus panel

1 reference

7 January 2021

AP-1 function and regulation

1 reference

7 January 2021

Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor

1 reference

7 January 2021

Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters

1 reference

7 January 2021

Constitutive expression of c-fos gene inhibits type 1 collagen synthesis in transfected osteoblasts

1 reference

7 January 2021

Persistent expression of proto-oncogene c-fos stimulates osteoclast differentiation

1 reference

7 January 2021

Studies on the contribution of c-fos/AP-1 to arthritic joint destruction

1 reference

7 January 2021

c-Fos/activator protein-1 transactivates wee1 kinase at G(1)/S to inhibit premature mitosis in antigen-specific Th1 cells

1 reference

7 January 2021

Human wee1 kinase is directly transactivated by and increased in association with c-Fos/AP-1: rheumatoid synovial cells overexpressing these genes go into aberrant mitosis

1 reference

7 January 2021

Interleukin-1 or phorbol induction of the stromelysin promoter requires an element that cooperates with AP-1.

1 reference

7 January 2021

AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element

1 reference

7 January 2021

Basic calcium phosphate crystals induce matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-Fos/AP-1/metalloproteinase 1 pathway. Involvement of transcription factor binding sites AP-1 and PEA-3

1 reference

7 January 2021

Integration of MAP kinase signal transduction pathways at the serum response element

1 reference

7 January 2021

Lessons from animal models of arthritis

1 reference

7 January 2021

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

1 reference

7 January 2021

Osteoclasts are essential for TNF-alpha-mediated joint destruction

1 reference

7 January 2021

The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice

1 reference

7 January 2021

Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice

1 reference

7 January 2021

Design, synthesis, and biological evaluation of new cyclic disulfide decapeptides that inhibit the binding of AP-1 to DNA.

1 reference

7 January 2021

Discovery of nonpeptidic small-molecule AP-1 inhibitors: lead hopping based on a three-dimensional pharmacophore model

1 reference

7 January 2021

Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA

1 reference

7 January 2021

Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos

1 reference

7 January 2021

Therapeutic strategies for rheumatoid arthritis

1 reference

7 January 2021

Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction

1 reference

7 January 2021

Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor

1 reference

7 January 2021

Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo

1 reference

7 January 2021

Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis.

1 reference

7 January 2021

Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus

1 reference

7 January 2021

Cadherin-11 in synovial lining formation and pathology in arthritis

1 reference

7 January 2021

The future of biologics in the treatment of rheumatoid arthritis

1 reference

7 January 2021

c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis

1 reference

7 January 2021

Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun.

1 reference

7 January 2021

Identifiers

DOI

10.1038/NBT1412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18587386%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference